secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2025-12-29T23:59:59+00:00
Accession:  0001999371-25-021283
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix Pharmaceuticals prices $20M registered direct offering with Point72; shares and pre-funded warrants
--------------------------------------------------------------------------------

- Sold 615,025 shares at $16.26 and pre-funded warrants for 615,025 shares at $16.259 to Point72; gross proceeds ~$20M.
- Closing expected Dec 30, 2025; TD Cowen sole placement agent.
- Net proceeds to fund commercialization, pipeline development, and working capital.
- 30-day lock-up on additional equity issuance; 180-day ban on variable rate transactions.
- Directors and officers also subject to 30-day lock-up.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125021283/0001999371-25-021283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000199937125021283/tonix-8k_122925.htm
  HTML page:      https://secwatch.observer/filing/0001999371-25-021283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer